Poxvirus immunotherapies in combination with immune checkpoint inhibitors synergize to eliminate tumors in a mouse tumor model
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Poxvirus immunotherapies in combination with immune checkpoint inhibitors synergize to eliminate tumors in a mouse tumor model ; volume:1 ; number:1 ; day:7 ; month:11 ; year:2013 ; pages:1 ; date:11.2013
Journal for ImmunoTherapy of Cancer ; 1, Heft 1 (7.11.2013), 1, 11.2013
- Creator
-
Foy, Susan P.
- Contributor
-
Rountree, Ryan B.
Mandl, Stefaine J.
Cote, Joseph
dela Cruz, Tracy
Gordon, Evan
Trent, Erica
Delcayre, Alain
SpringerLink (Online service)
- DOI
-
10.1186/2051-1426-1-S1-P72
- URN
-
urn:nbn:de:1111-2016072651271
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.09.2193, 3:54 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Foy, Susan P.
- Rountree, Ryan B.
- Mandl, Stefaine J.
- Cote, Joseph
- dela Cruz, Tracy
- Gordon, Evan
- Trent, Erica
- Delcayre, Alain
- SpringerLink (Online service)
Other Objects (12)
Immunotherapies in solid tumors
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Correction to: Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Fine-tuning anti-tumor immunotherapies via stochastic simulations
Combining talimogene laherparepvec with immunotherapies in melanoma and other solid tumors
The tumor immune microenvironment and T-cell-related immunotherapies in colorectal cancer
Nanotechnology‐Empowered Combination Cancer Immunotherapies: Mechanisms, Synergies, and Perspectives
TRAIL-induced programmed necrosis as a novel approach to eliminate tumor cells
Mining the mutanome: developing highly personalized Immunotherapies based on mutational analysis of tumors
Modeling human tumor-immune environments in vivo for the preclinical assessment of immunotherapies
Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers
Immunotherapies in solid tumors
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Correction to: Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Fine-tuning anti-tumor immunotherapies via stochastic simulations
Combining talimogene laherparepvec with immunotherapies in melanoma and other solid tumors
The tumor immune microenvironment and T-cell-related immunotherapies in colorectal cancer
Nanotechnology‐Empowered Combination Cancer Immunotherapies: Mechanisms, Synergies, and Perspectives
TRAIL-induced programmed necrosis as a novel approach to eliminate tumor cells
Mining the mutanome: developing highly personalized Immunotherapies based on mutational analysis of tumors
Modeling human tumor-immune environments in vivo for the preclinical assessment of immunotherapies
Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers
Immunotherapies in solid tumors
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Correction to: Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
Fine-tuning anti-tumor immunotherapies via stochastic simulations
Combining talimogene laherparepvec with immunotherapies in melanoma and other solid tumors
The tumor immune microenvironment and T-cell-related immunotherapies in colorectal cancer
Nanotechnology‐Empowered Combination Cancer Immunotherapies: Mechanisms, Synergies, and Perspectives
TRAIL-induced programmed necrosis as a novel approach to eliminate tumor cells
Mining the mutanome: developing highly personalized Immunotherapies based on mutational analysis of tumors
Modeling human tumor-immune environments in vivo for the preclinical assessment of immunotherapies